Showing 6801-6810 of 9381 results for "".
If you had to pick one—skydiving, bungee jumping, or scuba diving—which would you do?
https://practicaldermatology.com/topics/general-topics/if-you-had-to-pick-one-skydiving-bungee-jumping-or-scuba-diving-which-would-you-do/19831/Bruce Strober, MD says his choice is the one that offers him a whole new experience that he's never seen before. Watch now to learn his choice.DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleRe-opening and re-staffing: what to expect
https://practicaldermatology.com/topics/practice-management/re-opening-and-re-staffing-what-to-expect/19817/Reviving your dermatology practice is a team effort. You cannot do it without the support of your staff. This Ekwa Marketing video offers some tips to help navigate the logistics of staffing and keep everyone safe.Psoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of pDerm 2020: What’s New and in the Pipeline
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/derm-2020-whats-new-and-in-the-pipeline/19742/Michael Gold, MD shares insights on advances in aesthetic and medical dermatology, from novel devices to a new acne combination treatment being studied to skincare products, toxins and fillers coming to the US market.Gettin' Social With It
https://practicaldermatology.com/topics/practice-management/gettin-social-with-it/19728/An online presence is important, maybe even essential. But there are right and wrong ways to approach social media marketing. Joel Cohen, MD talks to Risa Luksa about the practices and pitfalls of social media.Surgery Not Required?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/surgery-not-required/19723/Patients increasingly want non-surgical options for skin tightening. Fortunately, a plethora of highly effective options exist, from ultrasound to radiofrequency, according to Mitchel Goldman, MD.The Science Driving Topicals Into the Future
https://practicaldermatology.com/topics/psoriasis/the-science-driving-topicals-into-the-future/19721/On the therapeutic front, one topic Neal Bhatia, MD is paying particularly close attention to is recent advances in vehicle science, which offer novel and intriguing strategies to improve delivery of topical applications to and through the skin.What Are You Looking Forward to at SDDS?
https://practicaldermatology.com/topics/practice-management/what-are-you-looking-forward-to-at-sdds/19717/Sarah Lonowski, MD, MBA, Division of Dermatology, University of California Los Angeles, Los Angeles talks about what she hopes to learn at the inaugural SDDS in May. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterContinental San Diego: sddeDermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of